Ascendis Pharma AS (MEX:ASNDN) OCF Margin %: -3.13% (As of Mar. 2026)


MEX:ASNDN Ascendis Pharma AS MEX:ASNDN
37 GF Score
Price MXN3,851.44
! 1 Warning Sign
View Full Analysis

What is Ascendis Pharma AS OCF Margin %?

Ascendis Pharma AS MEX:ASNDN 37 OCF Margin % is -3.13% as of Mar. 2026. GuruFocus rates MEX:ASNDN with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 960 Biotechnology companies, Ascendis Pharma AS ranks better than 73.23% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Ascendis Pharma AS's Cash Flow from Operations for the three months ended in Mar. 2026 was MXN-161 Mil. Ascendis Pharma AS's Revenue for the three months ended in Mar. 2026 was MXN5,141 Mil. Therefore, Ascendis Pharma AS's OCF Margin % for the quarter that ended in Mar. 2026 was -3.13%.

As of today, Ascendis Pharma AS's current OCF Yield % is 0.46%.

The historical rank and industry rank for Ascendis Pharma AS's OCF Margin % or its related term are showing as below:

MEX:ASNDN' s OCF Margin % Range Over the Past 10 Years
Min: -6214.41   Med: -1309.1   Max: 7.48
Current: 6.96

During the past 13 years, the highest OCF Margin % of Ascendis Pharma AS was 7.48%. The lowest was -6214.41%. And the median was -1309.10%.

MEX:ASNDN's OCF Margin % is ranked better than
73.23% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs MEX:ASNDN: 6.96

Ascendis Pharma AS OCF Margin % Related Terms

Ascendis Pharma AS OCF Margin % Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS OCF Margin % Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,369.63 -968.65 -175.23 -84.20 7.48

Ascendis Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.18 -4.64 1.01 29.66 -3.13

MEX:ASNDN vs SMMT, BBIO, JAZZ: OCF Margin % Comparison

For the Biotechnology subindustry, Ascendis Pharma AS's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's OCF Margin % falls into.


MEX:ASNDN
37GF Score
Ascendis Pharma AS MEX:ASNDN
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Ascendis Pharma AS's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=1136.362/15183.233
=7.48 %

Ascendis Pharma AS's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-160.96/5140.904
=-3.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -3.13% mean?
Ascendis Pharma AS (MEX:ASNDN) has a OCF Margin % of -3.13% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ascendis Pharma AS and its competitors. According to the industry distribution chart, Ascendis Pharma AS ranks #257 out of 960 companies in the Biotechnology industry, placing it in the top 26.8%.
Is Ascendis Pharma AS's OCF Margin % too high?
Ascendis Pharma AS's current OCF Margin % is -3.13%. Based on the distribution chart, Ascendis Pharma AS ranks #257 out of 960 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's OCF Margin % compare to SMMT and BBIO?
According to the Biotechnology industry distribution chart, Ascendis Pharma AS ranks #257 out of 960 companies for OCF Margin %. This puts Ascendis Pharma AS in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current OCF Margin % is -3.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (MEX:ASNDN) has a current OCF Margin % of -3.13%. The current OCF Margin % is -3.13%. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ascendis Pharma AS (MEX:ASNDN), the current OCF Margin % is -3.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges ASND:USA
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score

Get the complete analysis for MEX:ASNDN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,851.44
Price